Clinically Meaningful Improvement in Health-Related Quality of Life and the Association with Disease Activity in Psoriatic Arthritis after Treatment with Guselkumab: Results from a Randomized Placebo-Controlled Phase II Clinical Trial

Document Type

Abstract

Publication Date

9-2018

DOI

10.1002/art.40700

Journal Title

Arthritis and Rheumatology

Department

Dermatology

This document is currently not available here.

Share

COinS